查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496002

血管造影术设备市场 – 2024 年至 2029 年预测

Angiography Equipment Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 136 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

2022年血管造影术设备市值为149.02亿美元，预计复合年增长率为8.42%，到2029年达到262.36亿美元。

血管造影术是一种用于可视化血管并评估血流的医疗技术。显影剂注入血管并拍摄 X 光影像以获得详细影像。传统血管造影术使用电离辐射，而数位减影血管造影术则提高了可视性。萤光检查系统使用连续的 X 射线束，可以获得即时影像。

使用碘基或新型显影剂。非侵入性方法包括电脑断层扫描 (CTA)、磁振造影血管摄影 (MRA)、超音波系统和血流动力学监测系统。先进的血管造影术设备包括 3D 重建软体。全球癌症和心血管疾病盛行率上升是预计在预测期内推动血管造影术设备市场成长的关键因素之一。

老年人和肥胖人口的增加导致需要血管造影术的疾病迅速增加。此外，各新兴市场有关产品核可的有利政府法规也预计将推动全球市场的成长。此外，对微创手术偏好的改变也增加了对血管造影术系统的需求。

此外，血管造影术设备的技术创新和医疗流程的改进预计将有助于市场成长。然而，采购和使用技术先进的血管造影术设备的高成本是可能阻碍全球市场成长的主要因素。

市场驱动因素：

  • 心血管疾病盛行率的增加预示着市场的成长

在全球范围内，心血管疾病患者的数量多年来一直在迅速增加，这导致对血管造影术设备的需求增加，预计将在预测期内推动市场成长。根据《美国心臟病学会杂誌》2020 年 12 月发表的一篇论文，1990 年有 2.7 亿人患有心血管疾病，2019 年这一数字几乎翻了一番，达到 5.23 亿。死于心血管疾病的人数从1990年的1,210万人增加到2019年的1,860万人。

美国心臟协会 (AHA) 预测，45% 的美国将至少患有一种与心臟相关的问题。它还估计，2016 年至 2035 年间，与心血管疾病相关的费用将增加 100%。据世界卫生组织称，心血管疾病在主要死亡原因中所占比例最高。

该组织称，2019年，心血管疾病导致全球1,790万人死亡，占全球死亡人数的32%。随着心臟病盛行率的增加，过早死亡也在增加，2019 年因非传染性疾病导致的 1,700 万人过早死亡中，CVD 占 38%。 CVD 的成长趋势预计将在未来几年持续，并有望推动血管造影术设备市场的成长。

  • 不断增加的技术创新可能会增强血管造影术设备市场。

血管造影术设备市场不断增长的技术创新以及市场参与者推出先进的血管造影术设备预计将扩大血管造影术设备的范围并推动血管造影术设备在评估期内的成长。医疗设备製造商Kinepict Health开发了Kinepict医疗影像工具（KMIT）软体，该软体采用DVA（数位变异数血管摄影）技术。

2020年3月获得FDA批准，允许其在美国市场上市。此外，GE Healthcare 在北美放射学会 (RSNA) 2020 虚拟会议上宣布推出 Allia IGS 7血管造影术系统。该系统使用人工智慧，可以更好地利用旋转血管造影术。

多家公司推出了其他改善血管造影术流程的创新产品，预计将在预测期内推动血管造影术设备的成长。

北美地区占据主要市场占有率。

由于许多市场领导的存在以及心血管疾病的高盛行率，预计北美地区将占据很大的市场占有率。此外，先进的医疗保健系统的存在导致了新型血管造影术设备的采用。

随着心血管疾病病例数量的增加以及对该地区医疗保健部门的投资增加，预计该地区将显着增长，从而提供必要的医疗设施。

主要进展

  • 西门子 Healthineers 推出了 Atellica CI 分析仪，这是一款旨在解决实验室挑战的紧凑型测试系统。这款经 FDA 批准的分析仪提供可预测的交付时间、先进的报告功能和安全措施。它适用于中低测试量，目前在许多主要市场都有售。西门子 Healthineers 还推出了 Atellica Vantage 640 心血管血管造影术系统，该系统可为复杂的心臟手术提供卓越的影像品质并缩短扫描时间。飞利浦医疗保健公司的 Azurion Clarity 3D血管造影术系统可提供即时血管 3D 影像，而 GE 医疗保健公司的 Discovery™ HI FX40血管造影术系统可提供低剂量的高品质影像。
  • 2023 年 5 月 - GE Healthcare 的 Voluson(TM) Expert 22 在第七届年度医疗技术突破奖上被评为「最佳新型超音波技术解决方案」。该设备采用基于图形的自我调整波束形成器和人工智慧，每年在美国协助超过 360 万人出生。其 Lyric架构可实现即时资料处理并提供更清晰的 2D/3D/4D 成像。它还具有用户友好的触控萤幕显示器、简单的控制以及具有三种图像尺寸的高清超音波监视器。
  • 2022年11月－Canon引进红仁科技先进技术，开发出国内首个光子计数CT（PCT）系统。该设备将安装在国家癌症中心癌症研究和临床临床实验中心，用于PCT临床应用的研究。该系统配备了基于 Redren Technologies 开发的最新结晶製造和加工技术的先进模组化光子计数检测器，可在增加尺寸的同时降低製造和服务成本。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章血管造影术设备市场：依技术分类

  • 介绍
  • X血管造影术
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 血管造影术
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 血管造影术
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第六章血管造影术设备市场：依程序

  • 介绍
  • 冠状动脉
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 血管内的
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 神经血管的
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第七章血管造影术设备市场：按应用

  • 介绍
  • 诊断
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 治疗
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第八章血管造影术设备市场：依最终用户分类

  • 介绍
  • 医院/诊所
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 研究机构
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力
  • 诊断中心
    • 市场机会和趋势
    • 成长前景
    • 地域获利能力

第九章血管造影术设备市场：按地区

  • 介绍
  • 北美洲
    • 依技术
    • 透过治疗
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 依技术
    • 透过治疗
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 依技术
    • 透过治疗
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 依技术
    • 透过治疗
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 依技术
    • 透过治疗
    • 按用途
    • 按最终用户
    • 按国家/地区

第十章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十一章 公司简介

  • GE Healthcare
  • Siemens Healthcare
  • Philips Healthcare
  • Shimadzu Corporation
  • Canon Medical Systems Corporation
  • Carestream Health
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cordis Corporation
  • AngioDynamics, Inc.
简介目录
Product Code: KSI061611893

The angiography equipment market is evaluated at US$14.902 billion for 2022 and is projected to grow at a CAGR of 8.42% to reach US$26.236 billion by 2029.

Angiography is a medical technique used to visualize blood vessels and assess blood flow. It involves injecting a contrast agent into blood vessels and capturing X-ray images to obtain detailed images. Traditional angiography uses ionizing radiation, while Digital Subtraction Angiography enhances visibility. Fluoroscopy systems use continuous X-ray beams for real-time images.

Contrast agents, such as iodine-based or newer ones, are used. Non-invasive alternatives include Computed Tomography Angiography (CTA), Magnetic Resonance Angiography (MRA), ultrasound systems, and hemodynamic monitoring systems. Advanced angiography equipment includes 3D reconstruction software. The high prevalence, coupled with the increasing incidence of cancer and cardiovascular diseases around the world, is one of the major factors anticipated to drive the angiography equipment market growth during the forecast period.

The rise in the geriatric population and an increase in the growing number of obese people worldwide are leading to a surge in diseases that require angiography. Furthermore, favorable government regulations for the approval of the product in the various developed regions are also expected to fuel the growth of the global market. There is also a growing demand for angiography systems due to a shift in preference toward minimally invasive surgeries.

Moreover, growing innovations in angiography equipment are improving the medical process and, hence, are anticipated to contribute to the market growth. However, high costs associated with the procurement and use of technologically advanced angiography equipment are major factors likely to hamper the global market growth.

Market Drivers:

  • The increasing prevalence of cardiovascular diseases is anticipated in the market growth

The world has witnessed a surge in the number of cases of cardiovascular diseases over the years, which is leading to an increased demand for angiography equipment and is projected to boost market growth during the forecast period. A paper in the Journal of the American College of Cardiology stated in December 2020 that there were 270 million cases of cardiovascular diseases in 1990, which nearly doubled to 523 million in 2019. It also states that the number of people who died from cardiovascular disease increased from 12.1 million in 1990 to 18.6 million in 2019.

The American Heart Association (AHA) predicts that 45% of the population of the United States will have at least one heart-related problem. It also estimates that the costs related to cardiovascular diseases will increase by 100% between 2016 and 2035. According to WHO, cardiovascular disease has the highest share in the list of leading causes of death.

The organization states that cardiovascular diseases caused 17.9 million deaths in 2019 around the world and represented 32% of all deaths worldwide. Premature deaths are also increasing with the growing prevalence of heart diseases, with 38% of all the 17 million premature deaths due to non-communicable diseases caused by CVDs in 2019. The growing trend of CVDs is projected to continue in the coming years as well and is anticipated to drive the market growth of angiography equipment.

  • An increase in innovation would bolster the angiography equipment market.

The rising innovations in the market and the launch of advanced angiography equipment by the market players are widening the scope of angiography equipment and are anticipated to propel the growth of angiography equipment during the assessment period. The medical device company Kinepict Health has developed Kinepict Medical Imaging Tool (KMIT) software which uses Digital Variance Angiography (DVA) technology and provides superior image quality compared to the conventionally used technologies.

The FDA has given clearance for it in March 2020, allowing it to be launched in the U.S. market. Furthermore, GE Healthcare introduced the Allia IGS 7 angiography system at the Radiological Society of North America (RSNA) 2020 virtual meeting. The system uses artificial intelligence and allows better use of rotational angiography.

Various companies are launching several other innovative products that will improve the angiography process and are anticipated to spur the growth of angiography equipment during the forecast period.

North America region held a significant market share.

The North American region is anticipated to hold a significant market share owing to the presence of a large number of market leaders, coupled with a high prevalence of cardiovascular diseases. The presence of an advanced healthcare system also allows a larger adoption of new and advanced angiography equipment.

The region is anticipated to witness substantial growth due to the rising number of cases of CVDs, coupled with increased investments in the healthcare sector in the region, which will lead to the availability of requisite healthcare facilities.

Key Developments:

  • July 2023- Siemens Healthineers introduced the Atellica CI Analyzer, a compact testing system designed to address lab challenges. The FDA-cleared analyzer offers improved turnaround time predictability, advanced reporting functionality, and safety measures. It is suitable for low to medium testing volumes and is now available in many major markets. Siemens Healthineers also launched the Atellica Vantage 640 Cardiac Angiography System, which offers superior image quality and faster scan times for complex cardiac procedures. Philips Healthcare's Azurion Clarity 3D angiography system provides real-time 3D images of blood vessels, while GE Healthcare's Discovery(TM) HI FX40 angiography system offers high-quality images at low radiation doses.
  • May 2023- GE HealthCare's Voluson(TM) Expert 22 was named the "Best New Ultrasound Technology Solution" at the seventh annual MedTech Breakthrough Awards. The device, which uses an adaptive graphic-based beamformer and artificial intelligence, aids in over 3.6 million live births annually in the US. Its Lyric Architecture enables real-time data processing, resulting in sharper imaging in 2D/3D/4D. The device also features a user-friendly touch panel display, simple controls, and a high-definition ultrasound monitor with three image sizes. Clinicians can personalize the display and controls with exterior lighting colors, trackballs, and hard and soft keys.
  • November 2022- Canon Inc. developed the first domestically produced photon-counting CT (PCCT) system, incorporating Redlen Technologies Inc.'s advanced technologies. The system, installed at the National Cancer Center Japan Exploratory Oncology Research & Clinical Trial Center, is used for research exploring the clinical applications of PCCT. The system features an advanced modular photon-counting detector based on the latest crystal production/processing technologies developed by Redlen Technologies Inc., which allows for increased size while reducing manufacturing and service costs.

Market Segmentation:

By Technology

  • X-Ray Angiography
  • Computed Tomography Angiography
  • Magnetic Resonance Angiography

By Procedure

  • Coronary
  • Endovascular
  • Neurovascular

By Application

  • Diagnostic
  • Therapeutic

By End-User

  • Hospitals and Clinics
  • Research Institutes
  • Diagnostic Centers

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. ANGIOGRAPHY EQUIPMENT MARKET BY TECHNOLOGY

  • 5.1. Introduction
  • 5.2. X-Ray Angiography
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Computed Tomography Angiography
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Magnetic Resonance Angiography
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness

6. ANGIOGRAPHY EQUIPMENT MARKET BY PROCEDURE

  • 6.1. Introduction
  • 6.2. Coronary
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Endovascular
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Neurovascular
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness

7. ANGIOGRAPHY EQUIPMENT MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Diagnostic
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Therapeutic
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness

8. ANGIOGRAPHY EQUIPMENT MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
    • 8.2.1. Market Opportunities and Trends
    • 8.2.2. Growth Prospects
    • 8.2.3. Geographic Lucrativeness
  • 8.3. Research Institutes
    • 8.3.1. Market Opportunities and Trends
    • 8.3.2. Growth Prospects
    • 8.3.3. Geographic Lucrativeness
  • 8.4. Diagnostic Centers
    • 8.4.1. Market Opportunities and Trends
    • 8.4.2. Growth Prospects
    • 8.4.3. Geographic Lucrativeness

9. ANGIOGRAPHY EQUIPMENT MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Technology
    • 9.2.2. By Procedure
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. USA
        • 9.2.5.1.1. Market Opportunities and Trends
        • 9.2.5.1.2. Growth Prospects
      • 9.2.5.2. Canada
        • 9.2.5.2.1. Market Opportunities and Trends
        • 9.2.5.2.2. Growth Prospects
      • 9.2.5.3. Mexico
        • 9.2.5.3.1. Market Opportunities and Trends
        • 9.2.5.3.2. Growth Prospects
  • 9.3. South America
    • 9.3.1. By Technology
    • 9.3.2. By Procedure
    • 9.3.3. By Application
    • 9.3.4. By End-User
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
        • 9.3.5.1.1. Market Opportunities and Trends
        • 9.3.5.1.2. Growth Prospects
      • 9.3.5.2. Argentina
        • 9.3.5.2.1. Market Opportunities and Trends
        • 9.3.5.2.2. Growth Prospects
      • 9.3.5.3. Others
        • 9.3.5.3.1. Market Opportunities and Trends
        • 9.3.5.3.2. Growth Prospects
  • 9.4. Europe
    • 9.4.1. By Technology
    • 9.4.2. By Procedure
    • 9.4.3. By Application
    • 9.4.4. By End-User
    • 9.4.5. By Country
      • 9.4.5.1. Germany
        • 9.4.5.1.1. Market Opportunities and Trends
        • 9.4.5.1.2. Growth Prospects
      • 9.4.5.2. France
        • 9.4.5.2.1. Market Opportunities and Trends
        • 9.4.5.2.2. Growth Prospects
      • 9.4.5.3. UK
        • 9.4.5.3.1. Market Opportunities and Trends
        • 9.4.5.3.2. Growth Prospects
      • 9.4.5.4. Spain
        • 9.4.5.4.1. Market Opportunities and Trends
        • 9.4.5.4.2. Growth Prospects
      • 9.4.5.5. Others
        • 9.4.5.5.1. Market Opportunities and Trends
        • 9.4.5.5.2. Growth Prospects
  • 9.5. Middle East and Africa
    • 9.5.1. By Technology
    • 9.5.2. By Procedure
    • 9.5.3. By Application
    • 9.5.4. By End-User
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
        • 9.5.5.1.1. Market Opportunities and Trends
        • 9.5.5.1.2. Growth Prospects
      • 9.5.5.2. UAE
        • 9.5.5.2.1. Market Opportunities and Trends
        • 9.5.5.2.2. Growth Prospects
      • 9.5.5.3. Others
        • 9.5.5.3.1. Market Opportunities and Trends
        • 9.5.5.3.2. Growth Prospects
  • 9.6. Asia Pacific
    • 9.6.1. By Technology
    • 9.6.2. By Procedure
    • 9.6.3. By Application
    • 9.6.4. By End-User
    • 9.6.5. By Country
      • 9.6.5.1. China
        • 9.6.5.1.1. Market Opportunities and Trends
        • 9.6.5.1.2. Growth Prospects
      • 9.6.5.2. India
        • 9.6.5.2.1. Market Opportunities and Trends
        • 9.6.5.2.2. Growth Prospects
      • 9.6.5.3. Japan
        • 9.6.5.3.1. Market Opportunities and Trends
        • 9.6.5.3.2. Growth Prospects
      • 9.6.5.4. South Korea
        • 9.6.5.4.1. Market Opportunities and Trends
        • 9.6.5.4.2. Growth Prospects
      • 9.6.5.5. Taiwan
        • 9.6.5.5.1. Market Opportunities and Trends
        • 9.6.5.5.2. Growth Prospects
      • 9.6.5.6. Thailand
        • 9.6.5.6.1. Market Opportunities and Trends
        • 9.6.5.6.2. Growth Prospects
      • 9.6.5.7. Indonesia
        • 9.6.5.7.1. Market Opportunities and Trends
        • 9.6.5.7.2. Growth Prospects
      • 9.6.5.8. Others
        • 9.6.5.8.1. Market Opportunities and Trends
        • 9.6.5.8.2. Growth Prospects

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. GE Healthcare
  • 11.2. Siemens Healthcare
  • 11.3. Philips Healthcare
  • 11.4. Shimadzu Corporation
  • 11.5. Canon Medical Systems Corporation
  • 11.6. Carestream Health
  • 11.7. B. Braun Melsungen AG
  • 11.8. Boston Scientific Corporation
  • 11.9. Cordis Corporation
  • 11.10. AngioDynamics, Inc.